###begin article-title 0
###xml 78 86 <span type="species:ncbi:9606">patients</span>
Incidence of genetic polymorphisms involved in lipid metabolism among Chinese patients with osteonecrosis of the femoral head
###end article-title 0
###begin p 1
###xml 0 22 0 22 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Background and purpose</bold>
###xml 333 341 333 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(CYP3A4)</italic>
###xml 431 439 431 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(ABCB1),</italic>
###xml 117 125 <span type="species:ncbi:9606">patients</span>
###xml 528 536 <span type="species:ncbi:9606">patients</span>
Background and purpose Corticosteroid treatment is associated with osteonecrosis of the femoral head (ON) in certain patients. The degree of drug sensitivity in general is governed by genetic variation between individuals. We investigated the relationship between ON and the presence of different alleles of the cytochrome P450 gene (CYP3A4), the product of which metabolizes corticosteroids, and of the P-glycoprotein (P-gp) gene (ABCB1), the product of which modulates cellular uptake of corticosteroids, to determine whether patients with certain alleles may be at higher risk of ON after corticosteroid treatment.
###end p 1
###begin p 2
###xml 0 7 0 7 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Methods</bold>
###xml 228 234 228 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP3A4</italic>
###xml 240 270 240 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(CYP3A4*4, CYP3A4*5, CYP3A4*6)</italic>
###xml 289 294 289 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB1</italic>
###xml 22 30 <span type="species:ncbi:9606">patients</span>
###xml 151 159 <span type="species:ncbi:9606">patients</span>
###xml 172 179 <span type="species:ncbi:9606">Patient</span>
Methods We studied 31 patients from Guangdong, China who were both treated with corticosteroid therapy and developed ON, and 17 corticosteroid-therapy patients without ON. Patient DNA was screened for known polymorphisms in the CYP3A4 gene (CYP3A4*4, CYP3A4*5, CYP3A4*6) and the P-gp gene ABCB1 (mutations C3435T, G2677T/A).
###end p 2
###begin p 3
###xml 0 7 0 7 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Results</bold>
###xml 107 113 107 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB1,</italic>
###xml 246 251 246 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB1</italic>
###xml 371 376 371 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB1</italic>
###xml 429 435 429 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP3A4</italic>
###xml 59 67 <span type="species:ncbi:9606">patients</span>
###xml 478 486 <span type="species:ncbi:9606">patients</span>
Results The majority (20/31) of the corticosteroid-treated patients who developed ON were heterozygous for ABCB1, whereas only 3/17 without ON were heterozygous. Statistical significance was observed between the ON and the control groups for the ABCB1 G2677T/A polymorphism. Analysis of haplotypic frequencies indicated significant linkage disequilibrium between the two ABCB1 polymorphisms, C3435T and G2677T/A (D' = 0.034). No CYP3A4 polymorphisms were detected in any of the patients.
###end p 3
###begin p 4
###xml 0 14 0 14 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Interpretation</bold>
###xml 36 41 36 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB1</italic>
###xml 15 23 <span type="species:ncbi:9606">Patients</span>
###xml 401 409 <span type="species:ncbi:9606">patients</span>
Interpretation Patients carrying an ABCB1 polymorphism had a higher risk of having corticosteroid-associated ON than those with wild-type genotypes. This statistically significant association conflicts with previous studies, possibly due to different sampling methods. Knowing which genetic backgrounds are most strongly associated with corticosteroid-associated ON provides a method of screening for patients who are most at risk of developing ON.
###end p 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 312 333 312 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CIT0012">Lieberman et al. 2003</xref>
###xml 505 516 505 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CIT0013">Mankin 1992</xref>
###xml 704 724 704 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CIT0003">Drescher et al. 2006</xref>
###xml 972 984 972 984 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CIT0019">Schroer 1994</xref>
###xml 1311 1329 1311 1329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CIT0002">Asano et al. 2003b</xref>
###xml 1054 1062 <span type="species:ncbi:9606">patients</span>
Non-traumatic osteonecrosis (ON) of the femoral head is the gradual destruction of the femur head due to loss of blood flow and osteocyte death; it is characterized by disruption of intravascular blood flow, cellular toxicity, and impaired differentiation of mesenchymal cells, ultimately leading to bone death (Lieberman et al. 2003). Both arterial circulation-compromised by femoral neck fracture or arterial thrombosis/apoptosis from systemic diseases (e.g. lupus erythematous and hemoglobinopathies) (Mankin 1992)-and high intraosseous pressure, resulting from prolonged corticosteroid administration or ethanol abuse, obstruct blood flow in the femoral head and increase marrow cellularity and fat (Drescher et al. 2006). Although discreet pathogenetic mechanisms have yet to be identified in ON, corticosteroid and ethanol abuse have a profound effect on physiological bone turnover and oxygenation, and are associated with more than 90% of all osteonecrosis cases (Schroer 1994). The varying frequency and the clinical course of ON development in patients taking large doses of corticosteroids have been increasingly attributed (in part) to the presence of single nucleotide polymorphisms (SNPs) in the DNA sequences of genes encoding metabolic enzymes such as P-glycoprotein (P-gp) and cytochrome P450 (Asano et al. 2003b).
###end p 6
###begin p 7
###xml 134 151 134 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CIT0025">Tsuji et al. 1997</xref>
###xml 200 206 200 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(MDR1)</italic>
###xml 250 257 250 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(ABCB1)</italic>
###xml 264 283 264 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CIT0018">Sakaeda et al. 2002</xref>
###xml 347 364 347 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CIT0016">Saeki et al. 1993</xref>
###xml 388 393 388 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB1</italic>
###xml 552 570 552 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CIT0023">Tanabe et al. 2001</xref>
###xml 602 607 602 607 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB1</italic>
###xml 853 858 853 858 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB1</italic>
###xml 963 981 963 981 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CIT0023">Tanabe et al. 2001</xref>
###xml 983 1001 983 1001 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CIT0001">Asano et al. 2003a</xref>
P-gp is an ATP-dependent membrane efflux pump that maintains intracellular drug and xenobiotic concentrations below cytotoxic levels (Tsuji et al. 1997). P-gp is encoded by the multidrug-resistance 1 (MDR1) gene, also known as the ABC transporter B1 (ABCB1) gene (Sakaeda et al. 2002). Corticosteroids are well established to be a P-gp substrate (Saeki et al. 1993). Numerous SNPs in the ABCB1 gene have been identified, two of which (C3435T and G2677T/A) have been widely studied and associated with functional changes in P-gp expression or activity (Tanabe et al. 2001). Interindividual variation in ABCB1 may consequently modify P-gp expression and the pharmacokinetics of corticosteroids and metabolites, contributing to the cortisol sensitivity of certain individuals and increasing the risk of developing ON. A prognostic relationship between the ABCB1 C3435T and G2677T/A polymorphisms and cortisol-associated ON development has recently been established (Tanabe et al. 2001, Asano et al. 2003a).
###end p 7
###begin p 8
###xml 180 186 180 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP3A4</italic>
###xml 264 282 264 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CIT0009">Kitada et al. 1987</xref>
###xml 285 291 285 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP3A4</italic>
###xml 388 398 388 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP3A*1-*5</italic>
###xml 477 494 477 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CIT0007">Hsieh et al. 2001</xref>
###xml 623 641 623 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CIT0014">Masada et al. 2008</xref>
###xml 609 615 <span type="species:ncbi:9986">rabbit</span>
The cytochrome P450 family is a group of enzymes involved in the oxidative and reductive metabolism of almost all lipid-soluble medicines. The product of the cytochrome P450 gene, CYP3A4, is considered to be the main cytochrome responsible for steroid metabolism (Kitada et al. 1987). CYP3A4 also exhibits an approximate 40-fold degree of interindividual polymorphic variation, including CYP3A*1-*5 alleles, which have been associated with reduced activity of cytochrome P450 (Hsieh et al. 2001), a prognostic factor associated with increased incidence of ON and with the extent of necrotic infiltration in a rabbit model (Masada et al. 2008).
###end p 8
###begin p 9
###xml 66 71 66 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB1</italic>
###xml 127 164 127 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP3A4 (CYP3A4*4, CYP3A4*5, CYP3A4*6)</italic>
###xml 222 229 <span type="species:ncbi:9606">patient</span>
###xml 381 389 <span type="species:ncbi:9606">patients</span>
The objective of the present study was to assess the incidence of ABCB1 C3435T and G2677T/A genotypes, and of polymorphisms of CYP3A4 (CYP3A4*4, CYP3A4*5, CYP3A4*6) in a multicenter, randomized post-corticosteroid therapy patient cohort with or without corticosteroid-associated ON. Clarification of the prevalence of specific genetic polymorphisms in corticosteroid-associated ON patients will encourage greater acknowledgement of the prophylactic measures potentially available through individualized corticosteroid administration.
###end p 9
###begin title 10
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients and methods
###end title 10
###begin title 11
Study subjects
###end title 11
###begin p 12
###xml 549 569 549 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CIT0022">Sugano et al. (2002)</xref>
###xml 161 169 <span type="species:ncbi:9606">patients</span>
###xml 299 307 <span type="species:ncbi:9606">patients</span>
###xml 418 426 <span type="species:ncbi:9606">patients</span>
###xml 471 479 <span type="species:ncbi:9606">patients</span>
###xml 571 578 <span type="species:ncbi:9606">Patient</span>
###xml 742 749 <span type="species:ncbi:9606">patient</span>
###xml 787 795 <span type="species:ncbi:9606">patients</span>
###xml 944 952 <span type="species:ncbi:9606">Patients</span>
The study protocol was approved by the local institutional and administrative review board of the First Affiliated Hospital of Guangzhou TCM University, and all patients provided written informed consent before participation. All were from the Guangdong Province of China. 31 consecutive randomized patients who were treated with corticosteroid therapy and had documented ON, and 17 consecutive corticosteroid-therapy patients without ON were included in this study. The patients were diagnosed with ON in accordance with the criteria prescribed by Sugano et al. (2002). Patient history of corticosteroid use, exposure to hyperbaric conditions, known systemic and other concomitant diseases, and hemoglobinopathies were obtained by review of patient charts. Corticosteroid-associated ON patients were defined as those who took continuous corticosteroid medication for at least 2 months before physical and radiological examination of the hips. Patients with ON prior to corticosteroid administration or those with a history of ethanol abuse were excluded.
###end p 12
###begin title 13
Sequence analysis of the CYP3A4*4, CYP3A4*5, and CYP3A4*6 polymorphisms and the ABCB1 C3435T and G2677T/A polymorphisms
###end title 13
###begin p 14
###xml 0 18 0 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP3A4*4, CYP3A4*5</italic>
###xml 24 32 24 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP3A4*6</italic>
###xml 51 56 51 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB1</italic>
###xml 233 251 233 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CIT0001">Asano et al. 2003a</xref>
###xml 723 731 723 731 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP3A4*4</italic>
###xml 834 842 834 842 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP3A4*5</italic>
###xml 957 966 957 966 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP3A4*6.</italic>
###xml 989 994 989 994 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB1</italic>
###xml 199 206 <span type="species:ncbi:9606">patient</span>
CYP3A4*4, CYP3A4*5, and CYP3A4*6 polymorphisms and ABCB1 C3435T and G2677T/A polymorphisms were determined by sequencing polymerase chain reaction (PCR) products of the polymorphic regions from each patient, as previously described (Asano et al. 2003a). Briefly, genomic DNA for PCR was extracted from peripheral blood samples using the DNeasy Tissue Kit (Qiagen Gmbh, Hilden, Germany) following the manufacturer's instructions. Oligonucleotide primers for PCR amplification were derived from known sequences (GenBank accession number M29445 for C3435T and M29440 for G2677T/A). The sequences for the CYP primers were: forward 5'-CAC ATT TTC TAC AAC CAT GGA GAC C-3' and reverse 5'-TTT TAT ACC TGT CCC CAC CAG ATT C-3' for CYP3A4*4; forward 5'-TGT TGC ATG CAT AGA GGA AGG ATG G-3' and reverse 5'-GAT GAC AGG GTT TGT GAC AGG GG-3' for CYP3A4*5; and forward 5'-GAG CCA TAT TCT CAG AAG GGA GAT CAA G-3' and reverse 5'-CAA ACA TGT GTC GTT CTG CTA TGT GG-3' for CYP3A4*6. The sequences for the ABCB1 primers were: forward 5'-TTC AGC TGC TTG ATG GCA AA-3' and reverse 5'-AGG CAG TGA CTC GAT GAA GG-3' for C3435T; and forward 5'-CAG GCT TGC TGT AAT TAC CC-3' and reverse 5'-TAG TTT GAC TCA CCT TCC CA-3' for G2677T/A. The PCR amplification program consisted of an initial denaturation step at 94degreesC for 5 min, followed by 35 cycles of denaturation at 94degreesC for 1 min, annealing at 58degreesC for 1 min and extension at 72degreesC for 1 min, and a final extension at 72degreesC for 5 min. The resulting PCR fragments were then purified and sequenced using BigDye Terminator sequencing reactions in an automated DNA sequencer (ABI 3730; Applied Biosystems).
###end p 14
###begin title 15
Statistics
###end title 15
###begin p 16
###xml 210 215 210 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB1</italic>
###xml 469 487 469 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CIT0001">Asano et al. 2003a</xref>
###xml 37 44 <span type="species:ncbi:9606">patient</span>
###xml 117 125 <span type="species:ncbi:9606">patients</span>
###xml 144 152 <span type="species:ncbi:9606">patients</span>
Post-randomization clinical data and patient characteristics were stratified in terms of post-cortisol-associated ON patients and post-cortisol patients without ON. Statistical analysis of polymorphisms in the ABCB1 gene was conducted using the chi-square test or Fisher's exact test. Haplotype frequencies were estimated using pairwise linkage disequilibrium coefficients calculated from estimated haplotype frequencies of C3545T and G2677T/A as previously described (Asano et al. 2003a).
###end p 16
###begin title 17
Results
###end title 17
###begin title 18
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
Patient characteristics
###end title 18
###begin p 19
###xml 57 65 <span type="species:ncbi:9606">patients</span>
###xml 93 101 <span type="species:ncbi:9606">patients</span>
###xml 286 294 <span type="species:ncbi:9606">Patients</span>
###xml 392 400 <span type="species:ncbi:9606">patients</span>
###xml 720 728 <span type="species:ncbi:9606">patients</span>
The distribution of sex and age between the ON group (31 patients) and the control group (17 patients) was similar, with 14 females and 17 males with a median age of 32 (12-58) years in the ON group, and 9 females and 8 males with a median age of 30 (19-59) years in the control group. Patients were admitted for a variety of conditions requiring corticosteroid therapy. In the ON group, the patients were admitted for trauma (4), psoriasis (2), rubeola (2), renal disease (5), mixed connective tissue disease (3), systemic lupus erythematosus (7), atopy (2), rheumatoid arthritis (1), renal transplantation (1), asthma (1), mycotic opthalmia (1), aplastic anaemia (1), or chronic pharyngitis (1). In the control group, patients were admitted for renal disease (10) or systemic lupus erythematosus (7).
###end p 19
###begin title 20
Incidence of ABCB1 C3435T and G2677T/A polymorphisms
###end title 20
###begin p 21
###xml 49 54 49 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB1</italic>
###xml 13 21 <span type="species:ncbi:9606">patients</span>
###xml 207 215 <span type="species:ncbi:9606">patients</span>
Of the 31 ON patients who were genotyped for the ABCB1 C3435T polymorphism, 24 had the wild-type CC genotype, 7 had the heterozygous CT phenotype, and none had the homozygous TT phenotype. Of the 17 control patients, 14 had CC, 3 had CT, and none had TT.
###end p 21
###begin p 22
###xml 49 54 49 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB1</italic>
###xml 13 21 <span type="species:ncbi:9606">patients</span>
###xml 271 279 <span type="species:ncbi:9606">patients</span>
Of the 31 ON patients who were genotyped for the ABCB1 G2677T/A polymorphism, 18 had the wild-type GG genotype, 9 had the heterozygous GT phenotype, 4 had the heterozygous GA phenotype, and none had any of the remaining possible polymorphic phenotypes. Of the 17 control patients, all 17 had the wild-type GG phenotype.
###end p 22
###begin p 23
###xml 155 160 155 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB1</italic>
###xml 23 31 <span type="species:ncbi:9606">patients</span>
###xml 137 145 <span type="species:ncbi:9606">patients</span>
###xml 224 232 <span type="species:ncbi:9606">patients</span>
###xml 285 293 <span type="species:ncbi:9606">patients</span>
In the ON group, 20/31 patients carried one copy of a polymorphic allele of either C3435T (n = 7) or G2677T/A (n = 13), and 13 of all 31 patients carrying ABCB1 polymorphic alleles developed corticosteroid-associated ON. 24 patients homozygous for the wild-type 3435CC sequence and 18 patients homozygous for the 2677GG polymorphism developed ON subsequent to corticosteroid administration.
###end p 23
###begin p 24
###xml 122 129 122 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T0001">Table 1</xref>
###xml 318 338 318 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CIT0001">Asano et al. (2003a)</xref>
###xml 340 347 340 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T0002">Table 2</xref>
There was significant difference between the ON and control group for SNPs in the ABCB1 G2677T/A polymorphism (p = 0.002, Table 1). Analysis of haplotypic frequencies by Fisher's exact test indicated significant linkage disequilibrium between C3435T and G2677T/A (D' = 0.03), which is in agreement with the results of Asano et al. (2003a) (Table 2).
###end p 24
###begin p 25
Single nucleotide polymorphisms (SNPs) of ABCB1 exon 26 (C3435T) and exon 21 (G2677T/A) (n = 48)
###end p 25
###begin p 26
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 0 1 0 1 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>a</sup></bold>
a Fisher's exact test.
###end p 26
###begin p 27
Chi-squared test of independence for single nucleotide polymorphisms (SNPs) of ABCB1: C3435T and G2677T/A (n = 48)
###end p 27
###begin p 28
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 0 1 0 1 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>a</sup></bold>
a Fisher's exact test.
###end p 28
###begin p 29
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 0 1 0 1 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>b</sup></bold>
b Linkage disequilibrium coefficient (D')
###end p 29
###begin title 30
Incidence of CYP3A4*4, CYP3A4*5, and CYP3A4*6 polymorphisms
###end title 30
###begin p 31
###xml 28 46 28 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP3A4*4, CYP3A4*5</italic>
###xml 51 59 51 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP3A4*6</italic>
###xml 169 189 169 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CIT0002">Asano et al. (2003b)</xref>
Using sequence analysis, no CYP3A4*4, CYP3A4*5, or CYP3A4*6 polymorphisms were detected. These findings were discordant in part with the previously published results of Asano et al. (2003b).
###end p 31
###begin title 32
Discussion
###end title 32
###begin p 33
###xml 335 355 335 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CIT0001">Asano et al. (2003a)</xref>
###xml 661 666 661 666 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB1</italic>
###xml 735 756 735 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CIT0006">Hoffmeyer et al. 2000</xref>
###xml 758 773 758 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CIT0008">Kim et al. 2001</xref>
###xml 775 795 775 795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CIT0020">Siegmund et al. 2002</xref>
###xml 1087 1104 1087 1104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CIT0016">Saeki et al. 1993</xref>
###xml 1183 1205 1183 1205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CIT0020">Siegmund et al. (2002)</xref>
###xml 1619 1638 1619 1638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CIT0017">Sakaeda et al. 2001</xref>
###xml 1697 1702 1697 1702 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB1</italic>
###xml 1821 1842 1821 1842 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CIT0027">von Ahsen et al. 2001</xref>
###xml 1905 1922 1905 1922 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CIT0029">Yates et al. 2003</xref>
###xml 1233 1241 <span type="species:ncbi:9606">patients</span>
###xml 1528 1536 <span type="species:ncbi:9606">patients</span>
Our results indicate a statistically significant difference between the ON and control groups regarding the ABCB1 C3435T and G2677T/A SNPs, suggesting a positive association between these genetic polymorphisms and the susceptibility of corticosteroid-associated ON. It is interesting that this result conflicts with the observation of Asano et al. (2003a), in which the C3435T (3435TT genotype, but not 3435CT genotype) and G2677T/A (2677TT, 2677TA, and 2677AA genotypes) SNPs were associated with a reduced risk of corticosteroid-associated ON. Ethnic background should probably be considered to be the primary cause of this diversity. To date, 28 SNPs in the ABCB1 gene have been reported at 27 positions in Caucasians and Africans (Hoffmeyer et al. 2000, Kim et al. 2001, Siegmund et al. 2002), of which only a few C3435T SNPs were associated with P-gp expression, function, or increased plasma concentration. Other studies have also found a diversified allelic frequency in the wobble SNP in C3435T, with Caucasians and Japanese showing frequencies different from those of Africans (Saeki et al. 1993). The involvement of the 3435T variant allele has been reported previously by Siegmund et al. (2002), in which healthy Japanese patients harboring the allele had lower serum concentrations of digoxin after a single injection as compared to wild-type subjects. Other studies have shown conflicting results, with a lack of genotype-phenotype correlation between C3435T SNPs and cyclosporine efficacy in renal transplantation patients, indicating that C3435T is not the only polymorphism involved in P-gp expression (Sakaeda et al. 2001). However, recent studies have shown that carriers of the ABCB1 3435T allele have enhanced oral clearance of cyclosporine compared to Caucasian individuals with the 3435CC genotype (von Ahsen et al. 2001), and they have reduced expression of intestinal CYP3A4 mRNA (Yates et al. 2003).
###end p 33
###begin p 34
###xml 134 154 134 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CIT0001">Asano et al. (2003a)</xref>
###xml 193 198 193 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB1</italic>
###xml 617 634 617 634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CIT0016">Saeki et al. 1993</xref>
###xml 687 708 687 708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CIT0021">Siegsmund et al. 2002</xref>
###xml 835 855 835 855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CIT0020">Siegmund et al. 2002</xref>
A statistically significant linkage disequilibrium between the C3435T and G2677T/A SNPs was identified in both this study and that of Asano et al. (2003a), corroborating the involvement of the ABCB1 C3435T and G2677T/A SNPs in the pathogenesis of corticosteroid-associated ON. However, whether the involvement is a risk factor for or against corticosteroid-associated ON remains to be determined. Although the physiological role of P-gp remains elusive, interindividual expression of the highly polymorphic ABCB1 gene is likely to contribute to variability in the pharmacokinetics and pharmacodynamics of many drugs (Saeki et al. 1993) in addition to increased susceptibility to cancer (Siegsmund et al. 2002). C3435T and G2677T/A SNPs do not involve amino acid substitution and do not functionally influence P-gp expression directly (Siegmund et al. 2002). Thus, their functional significance may be that they are involved in post-transcriptional mRNA processing and affect the quality or quantity of P-gp protein expression.
###end p 34
###begin p 35
###xml 153 167 153 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CIT0011">Li et al. 2006</xref>
The frequencies of the C3435T alleles in our test groups were much different from those reported for normal healthy Han Chinese populations (reviewed in Li et al. 2006). Previous studies of Han Chinese populations from Singapore, southwest China, and Northern China showed a typical Hardy-Weinberg distribution of genotypes. In contrast, our data show a low frequency of T alleles. It is likely that our results may have been affected by both sampling error due to low sample size and by the fact that the samples came from unhealthy individuals. Similar conclusions may be drawn regarding the G2677T/A allele, based on its strong linkage to the C3435T allele.
###end p 35
###begin p 36
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP3A</italic>
###xml 142 147 142 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP3A</italic>
###xml 173 189 173 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CIT0010">Koch et al. 2002</xref>
###xml 216 222 216 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP3A4</italic>
###xml 227 233 227 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP3A5</italic>
###xml 362 367 362 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP3A</italic>
###xml 375 392 375 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CIT0007">Hsieh et al. 2001</xref>
###xml 496 505 496 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(CYP3A4*4</italic>
###xml 510 519 510 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP3A4*5)</italic>
###xml 587 604 587 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CIT0005">Felix et al. 1998</xref>
###xml 606 625 606 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CIT0024">Thervet et al. 2003</xref>
###xml 704 709 704 709 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP3A</italic>
###xml 864 881 864 881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CIT0007">Hsieh et al. 2001</xref>
###xml 883 898 883 898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CIT0028">Wen et al. 2004</xref>
###xml 1010 1024 1010 1024 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CIT0004">Du et al. 2006</xref>
###xml 1071 1076 1071 1076 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP3A</italic>
###xml 422 429 <span type="species:ncbi:9606">patient</span>
The CYP3A subfamily of cytochrome P450 proteins are found most abundantly in the liver and intestine, accounting for approximately 95% of the CYP3A mRNA-pool in Caucasians (Koch et al. 2002). The protein products of CYP3A4 and CYP3A5 are preferentially involved in the catalysis of exogenous and endogenous compounds. Contrary to the expected SNP variability of CYP3A genes (Hsieh et al. 2001), all of the subjects in our patient cohort were homozygous wild-types. Certain alleles of these genes (CYP3A4*4 and CYP3A4*5) are associated with clinically relevant changes in drug clearance (Felix et al. 1998, Thervet et al. 2003). Our study design did not allow for measurement of the systemic clearance of CYP3A substrate drugs in relation to development of ON; however, recent studies have shown that the CYP alleles we examined are rare in the Chinese population (Hsieh et al. 2001, Wen et al. 2004). Instead, the Chinese population contains a number of novel CYP mutations that are rare in other populations (Du et al. 2006). We suggest evaluation of the roles of other CYP3A genes in relation to ON and control groups, with clearly identifying the substrate regiments of the gene products in the future.
###end p 36
###begin p 37
###xml 112 128 112 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CIT0015">Naud et al. 2008</xref>
###xml 141 162 141 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="CIT0026">Tsujimura et al. 2005</xref>
###xml 23 31 <span type="species:ncbi:9606">patients</span>
Interestingly, all the patients who did not develop ON had either kidney disease or lupus. Both kidney disease (Naud et al. 2008) and lupus (Tsujimura et al. 2005) can increase P-gp activity. It is possible that these diseases counteracted any genetic influences on corticosteroid clearance by upregulating P-gp expression, thus providing protection against ON.
###end p 37
###begin title 38
Acknowledgements
###end title 38
###begin p 39
HEW wrote the study protocol and did the loading tests. LIK wrote the article and did the interpretation and statistical analysis of the data.
###end p 39
###begin p 40
This study was supported by the Chinese Postdoctoral Science Foundation, grant 29970410234, and the National Nature Science Foundation, grant 30672700.
###end p 40
###begin p 41
No competing interests declared.
###end p 41
###begin article-title 42
ABCB1 C3435T and G2677T/A polymorphism decreased the risk for steroid-induced osteonecrosis of the femoral head after kidney transplantation.
###end article-title 42
###begin article-title 43
Genetic analysis of steroid-induced osteonecrosis of the femoral head.
###end article-title 43
###begin article-title 44
Endothelin-1-induced femoral head epiphyseal artery constriction is enhanced by long-term corticosteroid treatment.
###end article-title 44
###begin article-title 45
Systematic screening for polymorphisms in the CYP3A4 gene in the Chinese population.
###end article-title 45
###begin article-title 46
Association of CYP3A4 genotype with treatment-related leukemia.
###end article-title 46
###begin article-title 47
###xml 32 37 <span type="species:ncbi:9606">human</span>
Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo.
###end article-title 47
###begin article-title 48
Novel mutations of CYP3A4 in Chinese.
###end article-title 48
###begin article-title 49
Identification of functionally variant MDR1 alleles among European Americans and African Americans.
###end article-title 49
###begin article-title 50
###xml 49 54 <span type="species:ncbi:9606">human</span>
Significance of cytochrome P-450 (P-450 HFLa) of human fetal livers in the steroid and drug oxidations.
###end article-title 50
###begin article-title 51
Interindividual variability and tissue-specificity in the expression of cytochrome P450 3A mRNA.
###end article-title 51
###begin article-title 52
Distribution of the functional MDR1 C3435T polymorphism in the Han population of China.
###end article-title 52
###begin article-title 53
Osteonecrosis of the hip: management in the 21st century.
###end article-title 53
###begin article-title 54
Nontraumatic necrosis of bone (osteonecrosis).
###end article-title 54
###begin article-title 55
###xml 113 119 <span type="species:ncbi:9986">rabbit</span>
Increased hepatic cytochrome P4503A activity decreases the risk of developing steroid-induced osteonecrosis in a rabbit model.
###end article-title 55
###begin article-title 56
Effects of chronic renal failure on liver drug transporters.
###end article-title 56
###begin article-title 57
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human P-glycoprotein transports cyclosporin A and FK506.
###end article-title 57
###begin article-title 58
MDR1 genotype-related pharmacokinetics of digoxin after single oral administration in healthy Japanese subjects.
###end article-title 58
###begin article-title 59
MDR1 genotype-related pharmacokinetics and pharmacodynamics.
###end article-title 59
###begin article-title 60
Current concepts on the pathogenesis of osteonecrosis of the femoral head.
###end article-title 60
###begin article-title 61
###xml 19 24 <span type="species:ncbi:9606">human</span>
The effects of the human MDR1 genotype on the expression of duodenal P-glycoprotein and disposition of the probe drug talinolol.
###end article-title 61
###begin article-title 62
Association of the P-glycoprotein transporter MDR1(C3435T) polymorphism with the susceptibility to renal epithelial tumors.
###end article-title 62
###begin article-title 63
The 2001 revised criteria for diagnosis, classification, and staging of idiopathic osteonecrosis of the femoral head.
###end article-title 63
###begin article-title 64
###xml 32 37 <span type="species:ncbi:9606">human</span>
Expression of P-glycoprotein in human placenta: relation to genetic polymorphism of the multidrug resistance (MDR)-1 gene.
###end article-title 64
###begin article-title 65
Impact of cytochrome p450 3A5 genetic polymorphism on tacrolimus doses and concentration-to-dose ratio in renal transplant recipients.
###end article-title 65
###begin article-title 66
Tissue distribution of the mdr gene product PGP and its physiological function.
###end article-title 66
###begin article-title 67
###xml 112 120 <span type="species:ncbi:9606">patients</span>
Clinical relevance of the expression of P-glycoprotein on peripheral blood lymphocytes to steroid resistance in patients with systemic lupus erythematosus.
###end article-title 67
###begin article-title 68
No influence of the MDR-1 C3435T polymorphism or a CYP3A4 promoter polymorphism (CYP3A4-V allele) on dose-adjusted cyclosporin A trough concentrations or rejection incidence in stable renal transplant recipients.
###end article-title 68
###begin article-title 69
Screening of 12 SNPs of CYP3A4 in a Chinese population using oligonucleotide microarray.
###end article-title 69
###begin article-title 70
###xml 106 114 <span type="species:ncbi:9606">patients</span>
The effect of CYP3A5 and MDR1 polymorphic expression on cyclosporine oral disposition in renal transplant patients.
###end article-title 70

